Date  |
|
| Dec 01, 2015 |
Avinger Announces Filing of 510(k) Application for Enhanced Version of Pantheris(TM) |
| Nov 24, 2015 |
Avinger, Inc. to Participate in Upcoming Investor Conferences |
| Nov 05, 2015 |
Avinger, Inc. Announces Third Quarter 2015 Results |
| Nov 03, 2015 |
Avinger, Inc. to Present at Upcoming Investor Conferences |
| Nov 02, 2015 |
Avinger Successfully Completes VISION IDE Trial for Pantheris(TM) |
| Oct 22, 2015 |
Avinger, Inc. to Announce Third Quarter 2015 Results on Thursday, November 5, 2015 |
| Oct 14, 2015 |
Avinger, Inc. Receives FDA 510(k) Clearance for Pantheris(TM) |
| Oct 13, 2015 |
Avinger Announces Interim Six-Month VISION Trial Results at TCT 2015 |
| Sep 23, 2015 |
Avinger, Inc. Secures Up to $55M in Financing From CRG |
| Aug 12, 2015 |
Avinger, Inc. Announces Early 510(k) Filing for Pantheris(TM) |